FDA Panel Endorses Another Hep C Drug
Posted on 28. Apr, 2011 by Dr. Ellis in News and Updates
(MedPage Today) — SILVER SPRING, Md. — Hepatitis C patients will likely have two new treatment options after an FDA advisory committee unanimously endorsed a second new HCV drug in as many days.
Read Full Article…
FDA Panel Gives Thumbs Up to Sunitinib for Pancreatic Tumors
Posted on 12. Apr, 2011 by Dr. Ellis in News and Updates
WASHINGTON (MedPage Today) — The FDA’s Oncologic Drugs Advisory Committee voted 8-2 Tuesday in favor of approving sunitinib (Sutent) to treat advanced pancreatic neuroendocrine tumors.
Read Full Article…
FDA Panel to Vote on Two Drugs for Pancreatic Cancer
Posted on 11. Apr, 2011 by Dr. Ellis in News and Updates
WASHINGTON (MedPage Today) — The FDA’s Oncology Drugs Advisory Committee will meet Tuesday to vote on whether approval should be granted for two new drugs to treat advanced pancreatic neuroendocrine tumors (pNET).
Read Full Article…
BREAKING NEWS:FDA Panel Endorses New Antibiotic for C. Diff
Posted on 05. Apr, 2011 by Dr. Ellis in News and Updates
(MedPage Today) — SILVER SPRING, Md. — An FDA advisory committee has voted unanimously to recommend approval of the investigational narrow-spectrum antibiotic fidaxomicin (Dificid) to treat Clostridium difficile-associated diarrhea.
Read Full Article…
Panel Digests Data Linking Food Coloring, Hyperactivity
Posted on 30. Mar, 2011 by Dr. Ellis in News and Updates
(MedPage Today) — SILVER SPRING, Md. — Judging from the data and the discussion during the first day of an FDA panel meeting on food dyes, it appears likely that juices, candies, cereals, yogurts, and hundreds of other everyday foods will maintain their brighter-than-bright hues.
Read Full Article…
FDA Panel Says Menthol Cigarettes Harmful
Posted on 18. Mar, 2011 by Dr. Ellis in News and Updates
WASHINGTON (MedPage Today) — Removing menthol from cigarettes would improve public health, according to a report from the FDA’s Tobacco Products Scientific Advisory Committee.
Read Full Article…
Brain Tumor Blaster Endorsed by FDA Panel
Posted on 17. Mar, 2011 by Dr. Ellis in News and Updates
(MedPage Today) — GAITHERSBURG, Md. — An FDA advisory panel says the benefits of a novel device that blasts glioblastoma multiforme brain tumors with an electrical field outweigh any risks.
Read Full Article…
FDA Panel to Vote on Approval, Dosing for COPD Drug
Posted on 07. Mar, 2011 by Dr. Ellis in News and Updates
WASHINGTON (MedPage Today) — An FDA advisory panel will vote Tuesday on whether a novel long-acting beta-adrenergic agonist is safe and effective at treating airflow obstruction in patients with chronic obstructive pulmonary disease.
Read Full Article…
FDA Panel: Keep ECT Devices as High Risk
Posted on 28. Jan, 2011 by Dr. Ellis in News and Updates
(MedPage Today) — GAITHERSBURG, Md. — The FDA should continue to regulate electroconvulsive therapy (ECT) machines as high-risk devices for treating depression and most other conditions for which ECT is typically used, members of the agency’s Neurological Devices Advisory Committee agreed.
Read Full Article…
FDA Panel Endorses CNS Contrast Agent
Posted on 21. Jan, 2011 by Dr. Ellis in News and Updates
WASHINGTON (MedPage Today) — An FDA panel has voted unanimously to recommend approval of a new contrast agent for MRI scans of the central nervous system.
Read Full Article…
